GSK enters agreement to acquire Nuvalent, Inc. – GSK

5 days ago

1 Views

1 Min Read

GSK enters agreement to acquire Nuvalent, Inc. GSK
GSK (Announcement): acquisition of late-stage biotech Hargreaves Lansdown
GSK’s $10.6bn cancer deal will lead to more Financial Times
GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm The Guardian
How GSK’s new boss sealed blockbuster biotech deal The Times